Results 131 to 140 of about 1,952,285 (318)

Case-Based Statistical Learning: A Non-Parametric Implementation With a Conditional-Error Rate SVM

, 2017
J. M. Górriz, Javier Ramı́rez, John Suckling, I. Álvarez, Andrés Ortíz, Francisco J. Martínez-Murcia, F. Segovia, D. Salas-González, Shuihua Wang‎   +8 more
openalex   +1 more source

Typographical Error [PDF]

JAMA, 2020
openaire   +2 more sources

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

Molecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung, David Bickel, Lena C. M. Krause, Daria Ezeriņa, Christian Ickes, Julian Wojtachnia, Christine S. Gibhardt, Magdalena Shumanska, Khadija Wahni, Andrea Paluschkiwitz, Julia Malo Pueyo, Ekaterina Baranova, Wim Vranken, Hedwig Stanisz, Ioana Stejerean‐Todoran, Michael P. Schön, Joris Messens, Ivan Bogeski   +17 more
wiley   +1 more source

The analysis of students’ mathematical representation errors in solving word problem related to graph

, 2018
Rahmah Johar, Khairiyah Rahma Lubis
openalex   +2 more sources

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Prevalence and predictors of prescribing errors in a primary care setting in Ghana. [PDF]

Ther Adv Drug Saf
Djochie RDA, Boakye-Yiadom J, Kwakye AO, Oppong KG, Mozu IE, Cobbold CC, Biney RP.   +6 more
europepmc   +1 more source

Dimensionality reduction by minimizing nearest-neighbor classification error

, 2010
Mauricio Villegas, Roberto Paredes
openalex   +2 more sources

The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity

Molecular Oncology, EarlyView.
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli, Alessio Bevilacqua, Mathias Wenes, Denis Migliorini, Lars van der Veen, Sigrid S Skånland, Giusy Di Conza, Kjetil Taskén   +7 more
wiley   +1 more source

Patient Safety 'Through Undergraduate Medical Students' Eyes': A Mixed-Methods Survey. [PDF]

Clin Teach
Pappa A, Xymitidis A, Strymponis T, Panagopoulou P, Fonseca VR, Martins H, Breda J, Tsimtsiou Z.   +7 more
europepmc   +1 more source

Data Error [PDF]

JAMA, 2019
openaire   +2 more sources